HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches
Tracking # 20-888656
Course overview
This CME/CMLE-accredited online course is designed to help Pathologists, laboratory professionals, and other members of the cancer care team apply the latest scientific evidence when evaluating HER2 status and be comfortable having an open dialogue surrounding challenging HER2 cases and how treatment is informed by HER2 status. Faculty also present information around how the emerging science around HER2-low may impact patient care. Learning Objectives: Upon completion of this activity, you should be able to: Apply key concepts from the ASCO/CAP 2018 focused update on HER2 testing in breast cancer Summarize recent clinical advances in the medical management of patients with HER2-positive breast cancer Describe the science and emerging evidence around the diagnosis and treatment of HER2-low breast cancer
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Disclosure statements
Supported by an independent educational grant from Daiichi Sankyo, Inc.